Print Page  |  Close Window

SEC Filings

S-8
TEVA PHARMACEUTICAL INDUSTRIES LTD filed this Form S-8 on 09/07/2017
Entire Document
 


         

Incorporated by Reference

    

Exhibit

No.

  

Description

  

Form

  

File No.

  

Exhibit

  

Filing Date

  

Filed

Herewith

  4.1    Amended and Restated Deposit Agreement, dated November  5, 2012, among Teva Pharmaceutical Industries Limited, JPMorgan Chase Bank, N.A., as depositary, and the owners and holders from time to time of American Depositary Shares issued thereunder, including the form of American Depositary Receipt contained therein    F-6    333-184652    99.(a)    October 30,
2012
  
  4.2    Amendment to Deposit Agreement, dated February  29, 2016, among Teva Pharmaceutical Industries Limited, JPMorgan Chase Bank, N.A., as depositary, and the owners and holders from time to time of American Depositary Shares issued thereunder, including the form of American Depositary Receipt contained therein    F-6 POS    333-208239    99.(a)(2)    February 29,
2016
  
  5.1    Opinion of Tulchinsky Stern Marciano Cohen Levitski & Co.                X
  5.2    Opinion of Kirkland & Ellis LLP                X
23.1    Consent of Kesselman & Kesselman – Independent Registered Public Accounting Firm to the Registrant                X
23.2    Consent of Tulchinsky Stern Marciano Cohen Levitski & Co. (included in Exhibit 5.1)                X
23.3    Consent of Kirkland & Ellis LLP (included in Exhibit 5.2)                X
24.1    Power of Attorney (included on signature page of this Registration Statement)                X
99.1    Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan    6-K    001-16174    Ex. A    June 8, 2017   
99.2    Teva Pharmaceutical Industries Limited 2008 Employee Stock Purchase Plan for U.S. Employees                X